Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/RGN stock hub

FRA/RGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/RGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.9B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/RGN

In the news

Latest news · FRA/RGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E59.3

P25 n/aP50 n/aP75 n/a

Trailing P/E132.7

P25 n/aP50 n/aP75 n/a

ROE2.5

P25 n/aP50 n/aP75 n/a

ROIC2.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/RGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,000
Employees Change	-5%
Employees Change Percent	-0.28
Enterprise value	EUR 5.8B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 5.9B
Price	EUR 106
Price currency	EUR
Rev Per Employee	331,021.96x
Sic	2836
Symbol	fra/RGN
Website	https://www.repligen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.75%
EV Earnings	130.88x
EV/EBIT	126.16x
EV/EBITDA	40.13x
EV/FCF	63.44x
EV/Sales	9x
FCF yield	1.55%
Forward P/E	59.31x
P/B ratio	3.24x
P/E ratio	132.73x
P/S ratio	8.94x
PE Ratio10 Y	265.09x
PE Ratio3 Y	782.03x
PE Ratio5 Y	432.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.13%
EBITDA Margin	17.59%
FCF margin	13.89%
Gross margin	53.14%
Gross Profit	EUR 351.8M
Gross Profit Growth	21.92%
Gross Profit Growth Q	18.51%
Gross Profit Growth3 Y	-0.77%
Gross Profit Growth5 Y	10.08%
Net Income	EUR 44.6M
Net Income Growth Q	42.93%
Net Income Growth3 Y	-30.68%
Net Income Growth5 Y	-8.37%
Pretax Margin	7.36%
Profit Margin	6.73%
Profit Per Employee	EUR 22,288
ROA	1.18
Roa5y	2.61
ROCE	1.94
ROE	2.51
Roe5y	4.18
ROIC	2.47
Roic5y	5.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.77%
Cagr15y	27.93%
Cagr1y	-6.51%
Cagr20y	20.95%
Cagr3y	-9.11%
Cagr5y	-7.22%
EPS Growth Q	47.87
EPS Growth3 Y	-30.48
EPS Growth5 Y	-8.97
FCF Growth	-15.03%
FCF Growth Q	106.13%
FCF Growth3 Y	4.11%
FCF Growth5 Y	23.81%
OCF Growth	-10.29%
OCF Growth Q	88.57%
OCF Growth10 Y	25.44%
OCF Growth3 Y	-6.54%
OCF Growth5 Y	15.95%
Revenue Growth	17.36x
Revenue Growth Q	14.83x
Revenue Growth3 Y	0.12x
Revenue Growth5 Y	12.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.26
Assets	EUR 2.5B
Cash	EUR 680.4M
Current Assets	EUR 984.8M
Current Liabilities	EUR 107M
Debt	EUR 596.4M
Debt EBITDA	EUR 4.02
Debt Equity	EUR 0.33
Debt FCF	EUR 6.48
Equity	EUR 1.8B
Interest Coverage	2.32
Liabilities	EUR 715.8M
Long Term Assets	EUR 1.6B
Long Term Liabilities	EUR 608.8M
Net Cash	EUR 84.1M
Net Cash By Market Cap	EUR 1.42
Net Cash Growth	616.21%
Net Debt EBITDA	EUR -0.72
Net Debt Equity	EUR -0.05
Net Debt FCF	EUR -0.91
Tangible Book Value	EUR 546.7M
Tangible Book Value Per Share	EUR 9.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.2
Inventory Turnover	2.15
Net Working Capital	EUR 235.6M
Quick ratio	7.45
Working Capital	EUR 897.8M
Working Capital Turnover	EUR 0.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	371.02%
1Y total return	-6.51%
200-day SMA	116.8
3Y total return	-24.93%
50-day SMA	102.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-31.24%
All Time High	278.7
All Time High Change	-61.86%
All Time High Date	2021-09-24
All Time Low	1.05
All Time Low Change	10,023.81%
All Time Low Date	2004-07-26
ATR	3.44
Ch YTD	-23.61
High	106.3
High52	147.1
High52 Date	2025-11-26
High52ch	-27.74%
Low	106.3
Low52	94.12
Low52 Date	2025-08-11
Low52ch	12.94%
Ma50ch	3.44%
Price vs 200-day SMA	-9.02%
RSI	53.21
RSI Monthly	43.78
RSI Weekly	45.25
Sharpe ratio	0.02x
Sortino ratio	0.16
Total Return	-1.01%
Tr YTD	-23.61
Tr15y	3,924.99%
Tr1m	6.41%
Tr1w	7.92%
Tr3m	-11.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 47.2M
Operating Income Growth	32.69
Operating Income Growth Q	102.2
Operating Income Growth3 Y	-29.21
Operating Income Growth5 Y	-11.6
Operating margin	7.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,369,073%
Shares Insiders	0.46%
Shares Institutions	114.24%
Shares Qo Q	0.01%
Shares Yo Y	1.01%
Short Ratio	5.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 62.8M
Average Volume	0.5x
Bv Per Share	32.38
CAPEX	EUR -21.4M
Ch10y	371
Ch15y	3,925
Ch1m	6.41
Ch1w	7.92
Ch1y	-6.51
Ch20y	4,385.2
Ch3m	-11.27
Ch3y	-24.93
Ch5y	-31.24
Ch6m	-14.52
Change	0.62%
Change From Open	0
Close	105.7
Days Gap	0.62
Depreciation Amortization	67,669,911.5
Earnings Date	2026-05-05
EBIT	EUR 47.2M
EBITDA	EUR 116.4M
EPS	EUR 0.79
F Score	7
FCF	EUR 92M
FCF EV Yield	1.58x
Financing CF	-13,632,221
Fiscal Year End	December
Founded	1,981
Goodwill	938,587,090.8
Graham Number	24.31404
Graham Upside	-77.13
Income Tax	EUR 4.2M
Investing CF	-198,051,424
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	EUR 4
Lynch Upside	-96.23
Ma150	121.8
Ma150ch	-12.74%
Ma20	104
Ma20ch	2.17%
Net CF	-97,648,440
Open	106.3
P FCF Ratio	64.33
P OCF Ratio	52.19
Ppne	243,454,130
Price Date	2026-05-08
Price EBITDA	EUR 50.82
Ptbv Ratio	10.82
Relative Volume	20x
Revenue	662,043,915x
SBC By Revenue	4.41x
Share Based Comp	29,188,114
Tax By Revenue	0.63x
Tax Rate	8.57%
Tr20y	4,385.23%
Tr6m	-14.52%
Z Score	6.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/RGN pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/RGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/RGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+114.2%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/RGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/RGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/RGN stock rating?

fra/RGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/RGN analysis?

The full report lives at /stocks/fra/RGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/RGN?

The latest report frames fra/RGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/RGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.